Global Engage is pleased to announce the 2nd Precision Medicine Congress which will be held on 14-15 September 2015 in London, UK. The meeting is part of our successful Drug Discovery series which includes innovative meetings on Digital Health, Digital Pathology, Human Microbiome, Synthetic Biology, qPCR / dPCR, & Biologics among others.
Recent advancements in the biomarker, CDx genomic and big data space have meant that some of the fundamental challenges of precision medicine are being realised. The potential for personalized medicine and therefore the possibility of delivering superior outcomes for patients is in reach. There is, however, a lot more to do. Alongside the continued developments in science as well as improvements in clinical trial design, support mechanisms such as market access /reimbursement/ regulatory strategies need to be further developed. Continued work by all stakeholders is therefore vital for success.